| # | Title | Journal | Year | Citations |
|---|
| 1 | A 12-Month Phase 3 Study of Pasireotide in Cushing's Disease | New England Journal of Medicine | 2012 | 550 |
| 2 | Growth hormone and the heart | Clinical Endocrinology | 2001 | 328 |
| 3 | Cardiovascular Risk Factors and Common Carotid Artery Caliber and Stiffness in Patients with Cushing’s Disease during Active Disease and 1 Year after Disease Remission | Journal of Clinical Endocrinology and Metabolism | 2003 | 314 |
| 4 | Growth-hormone and prolactin excess | Lancet, The | 1998 | 228 |
| 5 | Resistance to Cabergoline as Compared with Bromocriptine in Hyperprolactinemia: Prevalence, Clinical Definition, and Therapeutic Strategy | Journal of Clinical Endocrinology and Metabolism | 2001 | 200 |
| 6 | The GH–IGF‐I axis and the cardiovascular system: clinical implications | Clinical Endocrinology | 2008 | 178 |
| 7 | Clinical and biologic features of triple-negative breast cancers in a large cohort of patients with long-term follow-up | Breast Cancer Research and Treatment | 2012 | 175 |
| 8 | Cushing's Syndrome | Endocrinology and Metabolism Clinics of North America | 2008 | 166 |
| 9 | High prevalence of endocrine dysfunction in long-term survivors after allogeneic bone marrow transplantation for hematologic diseases | Cancer | 2002 | 155 |
| 10 | Increased Prevalence of Tricuspid Regurgitation in Patients with Prolactinomas Chronically Treated with Cabergoline | Journal of Clinical Endocrinology and Metabolism | 2008 | 154 |
| 11 | Sonic hedgehog-induced type 3 deiodinase blocks thyroid hormone action enhancing proliferation of normal and malignant keratinocytes | Proceedings of the National Academy of Sciences of the United States of America | 2007 | 149 |
| 12 | A Specific miRNA Signature Correlates With Complete Pathological Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer | International Journal of Radiation Oncology Biology Physics | 2012 | 149 |
| 13 | The Metabolic Syndrome and Cardiovascular Risk in Cushing's Syndrome | Endocrinology and Metabolism Clinics of North America | 2005 | 146 |
| 14 | Pathophysiology of Diabetes Mellitus in Cushing’s Syndrome | Neuroendocrinology | 2010 | 146 |
| 15 | Gemcitabine versus bacille Calmette‐Guérin after initial bacille Calmette‐Guérin failure in non‐muscle‐invasive bladder cancer | Cancer | 2010 | 144 |
| 16 | The FoxO3/type 2 deiodinase pathway is required for normal mouse myogenesis and muscle regeneration | Journal of Clinical Investigation | 2010 | 142 |
| 17 | Acromegaly | Journal of Clinical Endocrinology and Metabolism | 1997 | 130 |
| 18 | The prolactinoma | Best Practice and Research in Clinical Endocrinology and Metabolism | 2009 | 130 |
| 19 | Inferior petrosal sinus sampling in the differential diagnosis of Cushing's syndrome: results of an Italian multicenter study | European Journal of Endocrinology | 2001 | 128 |
| 20 | Dopamine Receptor Expression and Function in Clinically Nonfunctioning Pituitary Tumors: Comparison with the Effectiveness of Cabergoline Treatment | Journal of Clinical Endocrinology and Metabolism | 2004 | 120 |
| 21 | Local impact of thyroid hormone inactivation | Journal of Endocrinology | 2011 | 119 |
| 22 | The deiodinases and the control of intracellular thyroid hormone signaling during cellular differentiation | Biochimica Et Biophysica Acta - General Subjects | 2013 | 113 |
| 23 | Current approaches and perspectives in the therapy of medullary thyroid carcinoma | Cancer | 2001 | 111 |
| 24 | Bone Marker and Bone Density Responses to Dopamine Agonist Therapy in Hyperprolactinemic Males | Journal of Clinical Endocrinology and Metabolism | 1998 | 104 |
| 25 | Somatostatin analogs and prednisone in advanced refractory thymic tumors | Cancer | 2002 | 104 |
| 26 | Endoscopic pituitary surgery | Pituitary | 2008 | 103 |
| 27 | Effect of 2 years of cortisol normalization on the impaired bone mass and turnover in adolescent and adult patients with Cushing's disease: a prospective study | Clinical Endocrinology | 2003 | 99 |
| 28 | Avascular necrosis in long-term survivors after allogeneic or autologous stem cell transplantation | Cancer | 2003 | 92 |
| 29 | Prolactinomas in adolescents: persistent bone loss after 2 years of prolactin normalization | Clinical Endocrinology | 2000 | 91 |
| 30 | Nephrolithiasis in Cushing’s Disease: Prevalence, Etiopathogenesis, and Modification after Disease Cure | Journal of Clinical Endocrinology and Metabolism | 2003 | 91 |
| 31 | Results of a Single-Center Observational 10-Year Survey Study on Recurrence of Hyperprolactinemia after Pregnancy and Lactation | Journal of Clinical Endocrinology and Metabolism | 2013 | 89 |
| 32 | Reevaluation of growth hormone (GH) secretion in 69 adults diagnosed as GH-deficient patients during childhood. | Journal of Clinical Endocrinology and Metabolism | 1996 | 82 |
| 33 | Cardiovascular involvement in patients affected by acromegaly: An appraisal | International Journal of Cardiology | 2013 | 82 |
| 34 | Efficacy of combined treatment with lanreotide and cabergoline in selected therapy-resistant acromegalic patients | Pituitary | 1999 | 81 |
| 35 | Improvement of left ventricular hypertrophy and arrhythmias after lanreotide-induced GH and IGF-I decrease in acromegaly. A prospective multi-center study | Journal of Endocrinological Investigation | 2002 | 77 |
| 36 | Angiogenesis: A Target for Cancer Therapy | Current Pharmaceutical Design | 2004 | 72 |
| 37 | Cetuximab is an active treatment of metastatic and chemorefractory thymoma | Frontiers in Bioscience - Landmark | 2007 | 70 |
| 38 | First-line octreotide-LAR therapy induces tumour shrinkage and controls hormone excess in patients with acromegaly: results from an open, prospective, multicentre trial | Clinical Endocrinology | 2006 | 69 |
| 39 | Low glycaemic diet and metformin therapy: a new approach in male subjects with acne resistant to common treatments | Clinical and Experimental Dermatology | 2016 | 65 |
| 40 | Natural history of gastro-entero-pancreatic and thoracic neuroendocrine tumors. Data from a large prospective and retrospective Italian epidemiological study: the NET management study | Journal of Endocrinological Investigation | 2012 | 64 |
| 41 | Treatment of prolactinomas | Annals of Medicine | 1998 | 63 |
| 42 | Cinacalcet hydrochloride in combination with alendronate normalizes hypercalcemia and improves bone mineral density in patients with primary hyperparathyroidism | Endocrine | 2011 | 63 |
| 43 | Growth hormone, prolactin, and sexuality | Journal of Endocrinological Investigation | 2012 | 62 |
| 44 | Quantitative and functional expression of somatostatin receptor subtypes in human thymocytes | American Journal of Physiology - Endocrinology and Metabolism | 2002 | 61 |
| 45 | Reduced bone mass detected by bone quantitative ultrasonometry and DEXA in pre- and postmenopausal women with endogenous subclinical hyperthyroidism | Maturitas | 2004 | 60 |
| 46 | Cardiovascular risk in women with polycystic ovary syndrome | Fertility and Sterility | 2006 | 58 |
| 47 | PRL Secreting Adenomas in Male Patients | Pituitary | 2005 | 57 |
| 48 | Therapy of aggressive pituitary tumors | Expert Opinion on Pharmacotherapy | 2011 | 57 |
| 49 | Bone mineral density in acromegaly: the effect of gender, disease activity and gonadal status | Clinical Endocrinology | 2003 | 55 |
| 50 | Epidemiology; diagnosis, and treatment of male hypogonadotropic hypogonadism | Journal of Endocrinological Investigation | 2009 | 55 |
